Clough Capital Partners
Clough Capital Partners, L.P. is a Boston-based investment management firm
Business Model:
Revenue: $10.8M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Clough Capital Partners Information
Geographic Data
Address: 1290 N Broadway
City: Denver
State: CO
Zip: 80203
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
3,590,625Website Global Rank
3,766Website Monthly Traffic
Twitter Followers
Description
Clough Global Allocation is a close-ended balanced mutual fund, invests in the public equity and fixed income markets.
Contact Phone:
+18772568445
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2017 | ARMO BioSciences | Series C | 0 |
| 3/2021 | Amunix | Series B | 117M |
| 4/2021 | Arcellx | Series C | - |
| 1/2015 | Aduro BioTech | Series D | 51.4M |
| 4/2017 | Sienna Biopharmaceuticals | Series B | 0 |
| 10/2015 | Elcelyx Therapeutics | Series E | 0 |
| 6/2016 | CRISPR Therapeutics | Series B | 0 |
| 10/2019 | Arcellx | Series B | 0 |
| 6/2020 | Checkmate Pharmaceuticals | Series C | 85M |
| 9/2019 | Amphivena Therapeutics | Series C | 0 |
| 8/2017 | Apellis Pharmaceuticals | Series E | 0 |
| 4/2021 | Arcellx | Series C | - |
| 3/2021 | Amunix | Series B | 0 |
| 6/2020 | Checkmate Pharmaceuticals | Series C | 0 |
| 10/2019 | Arcellx | Series B | 0 |
| 9/2019 | Amphivena Therapeutics | Series C | 0 |
| 8/2017 | ARMO BioSciences | Series C | 0 |
| 8/2017 | Apellis Pharmaceuticals | Series E | 0 |
| 4/2017 | Sienna Biopharmaceuticals | Series B | 0 |
| 6/2016 | CRISPR Therapeutics | Series B | 0 |
| 10/2015 | Elcelyx Therapeutics | Series E | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
